Extended duration of the detectable stage by adding HPV test in cervical cancer screening

The human papillomavirus test (HPV) test could improve the (cost−) effectiveness of cervical screening by selecting women with a very low risk for cervical cancer during a long period. An analysis of a longitudinal study suggests that women with a negative Pap smear and a negative HPV test have a st...

Descripción completa

Detalles Bibliográficos
Autores principales: van den Akker-van Marie, M E, van Ballegooijen, M, Rozendaal, L, Meijer, C J L M, Habbema, J D F
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394464/
https://www.ncbi.nlm.nih.gov/pubmed/14612887
http://dx.doi.org/10.1038/sj.bjc.6601355
_version_ 1782155422448222208
author van den Akker-van Marie, M E
van Ballegooijen, M
Rozendaal, L
Meijer, C J L M
Habbema, J D F
author_facet van den Akker-van Marie, M E
van Ballegooijen, M
Rozendaal, L
Meijer, C J L M
Habbema, J D F
author_sort van den Akker-van Marie, M E
collection PubMed
description The human papillomavirus test (HPV) test could improve the (cost−) effectiveness of cervical screening by selecting women with a very low risk for cervical cancer during a long period. An analysis of a longitudinal study suggests that women with a negative Pap smear and a negative HPV test have a strongly reduced risk of developing cervical abnormalities in the years following the test, and that HPV testing lengthens the detectable stage by 2–5 years, compared to Pap smear detection alone.
format Text
id pubmed-2394464
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23944642009-09-10 Extended duration of the detectable stage by adding HPV test in cervical cancer screening van den Akker-van Marie, M E van Ballegooijen, M Rozendaal, L Meijer, C J L M Habbema, J D F Br J Cancer Short Communication The human papillomavirus test (HPV) test could improve the (cost−) effectiveness of cervical screening by selecting women with a very low risk for cervical cancer during a long period. An analysis of a longitudinal study suggests that women with a negative Pap smear and a negative HPV test have a strongly reduced risk of developing cervical abnormalities in the years following the test, and that HPV testing lengthens the detectable stage by 2–5 years, compared to Pap smear detection alone. Nature Publishing Group 2003-11-17 2003-11-11 /pmc/articles/PMC2394464/ /pubmed/14612887 http://dx.doi.org/10.1038/sj.bjc.6601355 Text en Copyright © 2003 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Short Communication
van den Akker-van Marie, M E
van Ballegooijen, M
Rozendaal, L
Meijer, C J L M
Habbema, J D F
Extended duration of the detectable stage by adding HPV test in cervical cancer screening
title Extended duration of the detectable stage by adding HPV test in cervical cancer screening
title_full Extended duration of the detectable stage by adding HPV test in cervical cancer screening
title_fullStr Extended duration of the detectable stage by adding HPV test in cervical cancer screening
title_full_unstemmed Extended duration of the detectable stage by adding HPV test in cervical cancer screening
title_short Extended duration of the detectable stage by adding HPV test in cervical cancer screening
title_sort extended duration of the detectable stage by adding hpv test in cervical cancer screening
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394464/
https://www.ncbi.nlm.nih.gov/pubmed/14612887
http://dx.doi.org/10.1038/sj.bjc.6601355
work_keys_str_mv AT vandenakkervanmarieme extendeddurationofthedetectablestagebyaddinghpvtestincervicalcancerscreening
AT vanballegooijenm extendeddurationofthedetectablestagebyaddinghpvtestincervicalcancerscreening
AT rozendaall extendeddurationofthedetectablestagebyaddinghpvtestincervicalcancerscreening
AT meijercjlm extendeddurationofthedetectablestagebyaddinghpvtestincervicalcancerscreening
AT habbemajdf extendeddurationofthedetectablestagebyaddinghpvtestincervicalcancerscreening

Ejemplares similares